Persist AI
YC W23 · Active · Developing long-lasting drug formulations 50% faster
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Inactive | YCW23 | |
| Other | Inactive | YCS18 | |
| AI | Active | YCW20 | |
| Other | Active | YCS19 | |
| Other | Active | YCW23 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Public | YCS20 | |
| Other | Not stated | Plug and Play | |
| AI | Active | YCX25 | |
| AI | Active | YCW17 | |
| Other | Active | YCW17 |
Also from W23 in AI
All of W23About Persist AI
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
- YC batch
- W23 · Winter 2023
- Status, per YC
- Active
- Category
- AI
- Team size
- 6
- Location
- Sacramento, CA, USA
- Checked
- 34m ago
YC tags: Machine Learning, Robotics, Microfluidics, Nanotechnology, Therapeutics
Persist AI: questions
Which YC batch was Persist AI in?
Persist AI was in Y Combinator's Winter 2023 batch (W23).
Is Persist AI still active?
Y Combinator lists Persist AI as active.
Where is Persist AI based?
Persist AI lists Sacramento, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.